Real-world evidence (RWE) can be leveraged to support use cases across the therapeutic development lifecycle. In a rapidly evolving clinical context, such as that of genitourinary cancers, real-world evidence is particularly useful when it comes to understanding how the changing landscape impacts treatment decision making and the patient experience.
In this webinar, Flatiron’s Eunice Hankinson, MSN, FNP-C, AOCNP will be joined by a panel of experts to discuss:
-
Research originally presented at the ASCO Genitourinary Cancer (GU) Symposium
- How scaled real-world data can unlock increasingly important biomarker-defined cohorts of interest
- Leveraging longitudinal patient data to gain insights into real-world treatment patterns and patient journeys
Panelists include:
- Amanda Nizam, MD, Associate Staff, Genitourinary Medical Oncology, Department of Hematology and Medical Oncology at Cleveland Clinic Taussig Cancer Institute
- Umang Swami, MD, MS, Assistant Professor of Oncology at Huntsman Cancer Institute, University of Utah
- Neeraj Agarwal, MD, FASCO, Professor of Medicine and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah
Read more of Flatiron's research.
